分子设计在有机I型光敏剂中的近期进展
Tao Xiong1, Yingchao Chen1, Mingle Li1
1State Key Laboratory of Fine Chemicals, College of Materials Science and Engineering, Shenzhen University, Shenzhen, 518071, China.
Small (Weinheim an der Bergstrasse, Germany)
|April 26, 2025
概括
本综述探讨了用于癌症治疗的I型光动力学疗法 (PDT),重点是设计克服瘤缺氧的光敏剂 (PSs). 它详细介绍了开发有效的抗低氧PDT药物的策略.
科学领域:
- 在瘤学瘤学.
- 照相疗法 照相疗法
- 药用化学 医学化学
背景情况:
- 光动力疗法 (PDT) 是一种有前途的非侵入性癌症治疗方法.
- 瘤缺氧限制了传统的依赖于活性氧物种的PDT的疗效.
- 第一种类型的PDT依赖于低氧依赖的基因生成,是新兴的替代方案.
研究的目的:
- 系统地审查最近在有机I型光敏化剂 (PSs) 的分子设计方面的进展.
- 提供对I型PS的设计原则的整体理解,特别是那些使用电子转移机制的PS.
- 为开发新型抗低氧PDT策略提供见解.
主要方法:
- 对有关有机I型光敏剂的最新文献进行系统审查.
- 分类分子设计策略成三个关键方法.
- 电子转移介导型I PDT机制的分析.
主要成果:
- 确定了I型PS分子设计的三个基本策略:调节电荷分布,利用低三元激发状态来抑制单元氧,并诱导激素形成的电子转移.
- 强调了电子转移机制在I型PDT中的重要性.
- 强调了I型PDT克服瘤缺氧的潜力.
结论:
- 对于I型PS的分子设计原理越来越清晰,为改善治疗疗效提供了途径.
- 对I型PS的进一步开发对推进抗低氧PDT具有显著的前景.
- 本综述为I型PS设计和PDT应用的未来研究提供了宝贵的见解.
更多相关视频
10:21Developing Photosensitizer-Cobaloxime Hybrids for Solar-Driven H2 Production in Aqueous Aerobic Conditions
Published on: October 5, 2019
8.3K
13:17In Vitro and In Vivo Evaluation of Photocontrolled Biologically Active Compounds - Potential Drug Candidates for Cancer Photopharmacology
Published on: September 29, 2023
2.1K
相关概念视频
Photosystem I
61.4K
Although structurally similar to photosystem II (PSII), photosystem I (PSI) is has a different electron supplier and electron acceptor.
Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...
Both these photosystems work in concert. An excited electron from PSII is relayed to PSI via an electron transport chain in the thylakoid membrane of the chloroplast, which is comprised of the carrier molecule plastoquinone, the dual-protein cytochrome complex, and plastocyanin. As electrons move between PSII and PSI, they lose energy and must be re-energized...
61.4K
Photochemical Electrocyclic Reactions: Stereochemistry
1.8K
The absorption of UV–visible light by conjugated systems causes the promotion of an electron from the ground state to the excited state. Consequently, photochemical electrocyclic reactions proceed via the excited-state HOMO rather than the ground-state HOMO. Since the ground- and excited-state HOMOs have different symmetries, the stereochemical outcome of electrocyclic reactions depends on the mode of activation; i.e., thermal or photochemical.
Selection Rules: Photochemical Activation
Selection Rules: Photochemical Activation
1.8K
Cycloaddition Reactions: MO Requirements for Photochemical Activation
2.0K
Some cycloaddition reactions are activated by heat, while others are initiated by light. For example, a [2 + 2] cycloaddition between two ethylene molecules occurs only in the presence of light. It is photochemically allowed but thermally forbidden.
2.0K
